Literature DB >> 1819700

A specific, sensitive and high-capacity immunoassay for PAF.

B A Baldo1, M A Smal, A C McCaskill.   

Abstract

A specific radioimmunoassay for platelet-activating factor (PAF) sensitive in the range 10-1000 pg (0.02-2 pmoles) has been developed. Detailed quantitative hapten inhibition studies showed specificity for the acetyl group at C-2 of PAF, a requirement for the ether linkage at C-1 and some tolerance for substituents on the choline nitrogen. No significant cross-reactivity was found with phosphatidylcholine and lysophosphatidylcholine or with lysoPAF.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1819700     DOI： 10.1007/BF02536517

Source DB:  PubMed          Journal:  Lipids        ISSN： 0024-4201            Impact factor:   1.880


  14 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Production of antibodies to platelet activating factor.

Authors:  M A Smal; B A Baldo; J W Redmond
Journal:  Mol Immunol       Date:  1989-08       Impact factor: 4.407

3.  Quantitation by radioimmunoassay of PAF in human saliva.

Authors:  S J Cooney; M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Endogenous platelet-activating factor and anti-platelet-activating factor in patients with renovascular hypertension.

Authors:  F Masugi; T Ogihara; S Saeki; K Sakaguchi; Y Kumahara; K Satouchi; M Oda; K Saito; K Tokunaga
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

5.  Examination for platelet-activating factor production by preimplantation mouse embryos using a specific radioimmunoassay.

Authors:  M A Smal; M Dziadek; S J Cooney; M Attard; B A Baldo
Journal:  J Reprod Fertil       Date:  1990-11

6.  The presence of platelet-activating factor (PAF) in normal human mixed saliva.

Authors:  C P Cox; M L Wardlow; R Jorgensen; R S Farr
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

7.  Existence of endogenous inhibitors of platelet-activating factor (PAF) with PAF in rat uterus.

Authors:  R Nakayama; K Yasuda; K Saito
Journal:  J Biol Chem       Date:  1987-09-25       Impact factor: 5.157

8.  Occurrence of an endogenous inhibitor of platelet-activating factor in rat liver.

Authors:  M Miwa; C Hill; R Kumar; J Sugatani; M S Olson; D J Hanahan
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

9.  Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry.

Authors:  C S Ramesha; W C Pickett
Journal:  Biomed Environ Mass Spectrom       Date:  1986-03

10.  Inhibitor(s) of platelet-activating factor (PAF) in human saliva.

Authors:  M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880
View more
  4 in total

1.  Quantitation by radioimmunoassay of PAF in human saliva.

Authors:  S J Cooney; M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Synthesis of a PAF immunogen and production of PAF-specific antibodies.

Authors:  M A Smal; B A Baldo; J W Redmond
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Inhibitor(s) of platelet-activating factor (PAF) in human saliva.

Authors:  M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis.

Authors:  Yves Denizot; Eric Liozon; Laurence Guglielmi; Kim Ly; Pascale Soria; Véronique Loustaud; Elisabeth Vidal; Marie Odile Jauberteau
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.